Lars Lund is appointed as senior consultant professor and head of research at the Department of Urology, Odense University Hospital and Clinical Institute, University of Southern Denmark (SDU) the 1st October 1, 2012. Since 2016 he is also adjunct professor at Aalborg University Hospital.
The research areas are cryo ablation (freezing treatment) of cancer especially in the kidney and prostate. His teams do research in stem cell therapy for erectile dysfunction and low-intensity shockwave treatment for erectile dysfunction and deteriorated kidney function.
Lars Lund was born in Aalborg, and graduated from Aalborghus Amtsgymnasium in 1975. Then he went to Aarhus, where he studied medicine and received his degree in 1984. The surgical and urological education took place in Aalborg, Randers, Skejby Urological Division, and was completed after one year's stay at the Child Surgical Department, Prince of Wales University Hospital, Hong Kong. In 1994 he became a specialist in surgery and 1998 in urology. Lars Lund has been employed as a head of urology and surgery at Viborg Hospital since 1998, interrupted by one year's stay at Vanderbilt University, Nashville, Tennessee in 2006.
He defended his doctoral dissertation on varicocele testis in 2001.
During his career, Lars Lund has taught several places, including clinical education at Randers Hospital, Aarhus University Hospital, Skejby and Aarhus University as well as at professional meetings at home and abroad. Teaching now at SDU in urinary tract diseases both at the barchelor and the candidate part. Lars Lund has been a distinguished clinical lecturer since 1994 and postgraduate clinical lecturer in urology at CEPOME, Aarhus University in the period 2003 to 2012. Lars Lund has published over 170 scientific articles. Has been and is the main supervisor of several Ph-D students, elite students and research students at SDU. He is a member of several committees: President of the Danish Urological Society, censor of the surgical thesis, consultant in patient care urology, and is president of the national multidisciplinary group for kidney cancer in Denmark (Darenca) and president of Norenca (the nordic group for renal cancer (www.NUF).
He is editor of the Danish Medical Journal since 2020.
